Search Results 301-310 of 18671 for detox protocol

1. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

   This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...

2. A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

3. Mayo Clinic Q and A: 10 nutrition myths debunked

   Any diet or eating program that eliminates an entire food group gets a red flag, as one is likely to miss out on vital nutrients. A detox diet will clean toxins ...

4. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

5. Publications - Ruth E. DeFoster, M.D. - Mayo Clinic

   Weighted Blankets for Agitation in Hospitalized Patients with Dementia: Protocol for a Randomized Controlled Trial. ... Use of Gabapentin for Alcohol Withdrawal ...

6. Food allergy vs. food intolerance: What's the difference? - Mayo Clinic

   Candida cleanse diet · Share · Tweet. Feb. 28, 2024 ... Candida cleanse diet · Diarrhea · Food allergy ... Executive Health Program · International Business ...

7. Swimmer's ear - Diagnosis & treatment - Mayo Clinic

   ... Alumni Association · Refer a Patient · Businesses · Executive Health Program · International Business Collaborations · Facilities & Real Estate · Supplier ...

8. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

10. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

    All patients will be followed up until disease progression, death, or unacceptable toxicity, or study withdrawal for any reason, whichever occurs first. Mayo ...